U.S. health plan coverage of Neuromuscular Disease Therapies: An assessment of policy availability and restrictions
{{output}}
Background: Health plan policies managing neuromuscular disease (NMD) therapies may impose burdensome requirements on patients and providers. While prior research has explored payer restrictions for rare NMD treatments, limited e... ...
